Wed.Nov 06, 2024

article thumbnail

Novavax coughs up $123.8M to settle COVID vaccine supply dispute with UK

Fierce Pharma

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a past COVID-19 vaccine supply deal. The Maryland biotech has agreed to pay $123.8 million to end a COVID vaccine supply pact with the U.K.

333
333
article thumbnail

XRHealth buys NeuroReality in health XR marriage

pharmaphorum

Two players in medical extended reality (XR) – XRHealth and NeuroReality – have come together in a quest to build the biggest company in the sector.Boston, US-based XRHealth is leading the deal, acquiring NeuroReality of the Netherlands for an undisclosed sum, combining their products and expertise in the use of XR and virtual reality software for healthcare applications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report

Fierce Pharma

Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report kdunleavy Wed, 11/06/2024 - 09:23

251
251
article thumbnail

Acadia Pharma Sells Voucher for Speedier FDA Drug Review for $150M

MedCity News

Acadia Pharmaceuticals did not disclose the buyer of the priority review voucher. The biotech received the voucher last year alongside the regulatory decision that made its drug Daybue the first FDA-approved treatment for the rare disease Rett syndrome. The post Acadia Pharma Sells Voucher for Speedier FDA Drug Review for $150M appeared first on MedCity News.

FDA 108
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy

Fierce Pharma

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its GLP-1 stalwarts Ozempic and Wegovy is more of a mixed bag. | Among Novo’s semaglutide-based drugs, diabetes blockbuster Ozempic fell short of analysts' expectations during the third quarter while weight-loss med Wegovy came above a consensus estimate.

Sales 227
article thumbnail

4 Areas Within Mental Health Care that Give Executives Hope

MedCity News

Mental health experts are hopeful about the de-stigmatization of behavioral health, the promise of AI and other areas, they shared at a recent conference. The post 4 Areas Within Mental Health Care that Give Executives Hope appeared first on MedCity News.

105
105

More Trending

article thumbnail

Patients Across the Country Deserve Better Access to Healthcare

MedCity News

By focusing on integrating care teams, expanding community programs, and addressing SDoH through policy reform, we can create a healthcare system that serves all patients — especially those most in need. The post Patients Across the Country Deserve Better Access to Healthcare appeared first on MedCity News.

article thumbnail

First-of-a-kind EU approval granted for eosinophilic esophagitis medicine

European Pharmaceutical Review

Dupixent (dupilumab) has been approved by the European Medicines Agency (EMA) as the first treatment for young children with eosinophilic esophagitis in the EU. This authorisation is based on Phase III data which found that 68 percent of children aged one to 11 years given Dupixent (dupilumab) achieved histological disease remission at 16 weeks. This result was maintained for up to one year.

Medicine 105
article thumbnail

What My Daughter’s Harrowing Alaska Airlines Flight Taught Me About Healthcare

MedCity News

As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives in its hands — I took from this terrifying incident a new guiding principle. Healthcare needs to pursue a zero-failure rate. The post What My Daughter’s Harrowing Alaska Airlines Flight Taught Me About Healthcare appeared first on MedCity News.

article thumbnail

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

Pharmaceutical Technology

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved following the interest rate cuts by the US Federal Reserve in September 2024.

Biopharma 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Alligator pancreatic cancer drug 'nearly doubles' survival

pharmaphorum

New results with Alligator's CD40 agonist mitazalimab show it nearly doubled survival in pancreatic cancer, ahead of phase 3 trial next year.

102
102
article thumbnail

The Future of Temperature-Controlled Technology

Pharmaceutical Commerce

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Delphine Perridy, chief commercial officer, Envirotainer, forecasts the future of the pharma cold chain regarding technological advancements and changes in market dynamics.

Pharma 59
article thumbnail

Wegovy romps ahead after key rival sees slowdown

pharmaphorum

Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing results three months ago.

Sales 81
article thumbnail

MHRA grants approval for bladder cancer drug erdafitinib

PharmaTimes

New therapy targets specific genetic alterations, promises extended survival

88
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Revolutionizing Digital Marketing in Pharma: Strategies for Success

Pharma Marketing Network

The world of digital marketing in pharma is evolving rapidly. With technological advances and changing consumer expectations, the industry must adapt or risk falling behind. Pharma marketing executives face the unique challenge of staying compliant while engaging audiences in meaningful ways. So, how can digital marketing truly revolutionize the pharma space?

article thumbnail

Arcellx to present positive data on multiple myeloma treatments

PharmaTimes

Phase 1 and 2 studies show promising results for anito-cel therapy

90
article thumbnail

Leveraging healthcare data analytics to ensure provider quality and profitability

Clarify Health

Now more than ever, health plans are under increasing pressure to deliver high-quality, cost-effective care across their provider networks. Balancing quality and profitability requires more than just contracting with providers; it demands a strategic approach to network management that prioritizes both performance and efficiency. One of the most powerful tools available for achieving this balance is healthcare data analytics.

article thumbnail

Dealmaking and Partnerships: The Future of Financing Innovation

PharmExec

At the Financial Times’ Global Pharma and Biotech Summit 2024, a breakout panel discussed how dealmaking remains vital for biopharma companies facing pipeline and revenue pressures.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Tevogen Bio partners Microsoft for HPV treatment

Pharmaceutical Technology

Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the development of an HPV specific CTL treatment.

64
article thumbnail

How to Bring World’s Most Innovative Treatments to Least Wealthy Places

PharmExec

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed initiatives aimed at bringing cell and gene therapies to low- and middle-income countries.

Pharma 52
article thumbnail

A diabetes drug, twice rejected, stumbles again — but its developer persists

PharmaVoice

After multiple rejections, Lexicon Pharmaceuticals is inching toward an FDA decision date next month for its adjunct type 1 diabetes therapy.

FDA 59
article thumbnail

Experts Weigh-In on Compounded GLP-1/Semaglutide Solution

PharmExec

Industry experts comment on the increasing popularity of compounded medications, particularly GLP-1s, due to drug shortages and the desire for personalized treatments.

Medical 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

DeepMind Nobel Prize winner says AI will have “electricity” type of impact

Pharmaceutical Technology

Demis Hassabis, joint winner of the Nobel Prize in Chemistry 2024, shared insights on AI at the FT Pharma and Biotech Summit.

Pharma 59
article thumbnail

Potential Implications of Phasing-Out Cookies

PharmExec

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explored the potential implications of the phase-out of cookies for the broader advertising industry.

52
article thumbnail

Data Governance, Data Integrity, and Data Quality: What’s the Connection?

PharmaTech

Data governance, data integrity, and data quality are all widely used terms, but what do they actually mean and how are they connected?

article thumbnail

Pharma Pulse 11/6/24: Enacting Sustainable Practices, Pharmacist Provider Status Is Growing & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Intra-Cellular bolsters Caplyta data with another Phase III win

Pharmaceutical Technology

The FDA-approved schizophrenia and bipolar disorder therapy met the primary and secondary endpoint in a Phase III “withdrawal trial”.

FDA 52
article thumbnail

Automate Aseptic Filling: Closing the System at Full Modularity

PharmaTech

Shifting to automated, closed modular manufacturing systems is growing increasingly crucial for biopharmaceutical production.

article thumbnail

Zentiva voices UWWTD concerns as EU grants approval

Pharmaceutical Technology

The UWWTD will require manufacturers to fund micropollutant removal, but Zentiva says the financial squeeze could mean shortages.

article thumbnail

Navigating Digital Transformation Fatigue: The Strategy for Success in Regulated Industries

Pharmaceutical Commerce

Digital transformation initiatives are often complex endeavors that can significantly impact the way organizations operate.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A